FORMOFLO FORTE (Formoterol (12mcg) + Fluticasone Propionate (500mcg))
-15%

FORMOFLO FORTE (Formoterol (12mcg) + Fluticasone Propionate (500mcg))

Original price was: ₹615.80.Current price is: ₹525.44.

Placeholder

Original price was: ₹615.80.Current price is: ₹525.44.

Add to cart
Buy Now
Category: Tag:

Formoflo Forte Transcaps is indicated for managing asthma symptoms, such as wheezing and breathlessness, as well as for chronic obstructive pulmonary disease (COPD), a condition characterized by obstructed airflow in the lungs. The medication works by relaxing the muscles in the airways, thus facilitating easier breathing. It is crucial to adhere to your healthcare provider’s guidance regarding the frequency of inhaler use, as taking the smallest effective dose is essential for optimal asthma management. Although the effects of this treatment may become apparent within a few days, the full therapeutic benefit typically manifests over several weeks. Consistent use of the medication is vital, even when symptoms are not present, to maintain control over asthma and COPD, as ceasing use may lead to a deterioration of your condition. This product is not intended for the immediate relief of acute asthma attacks; therefore, a rescue inhaler should be activated during such episodes. Proper inhalation technique is necessary to ensure maximum efficacy of the medication, so ensure you are familiar with the correct method. If you experience any side effects, speak with your healthcare provider rather than discontinuing the medication. To alleviate some common side effects, consider rinsing your mouth and throat with water or brushing your teeth following inhaler use. Be aware that while some side effects are more common, others are rarer but can be serious. Discuss any concerns with your doctor, and take precautionary measures to avoid asthma triggers and smoking.

Reviews

There are no reviews yet.

Be the first to review “FORMOFLO FORTE (Formoterol (12mcg) + Fluticasone Propionate (500mcg))”

Your email address will not be published. Required fields are marked *

Top